Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 70 entries
Sorted by: Best Match Show Resources per page
Anemia in Clinical Practice: Introduction.

Seminars in hematology

Cappellini MD, Beris P.
PMID: 26404437
Semin Hematol. 2015 Oct;52(4):259-60. doi: 10.1053/j.seminhematol.2015.07.001. Epub 2015 Jul 10.

No abstract available.

Cite
Cappellini MD, Beris P. Anemia in Clinical Practice: Introduction. Semin Hematol. 2015;52(4):259-60doi: 10.1053/j.seminhematol.2015.07.001.
Cappellini, M. D., & Beris, P. (2015). Anemia in Clinical Practice: Introduction. Seminars in hematology, 52(4), 259-60. https://doi.org/10.1053/j.seminhematol.2015.07.001
Cappellini, Maria-Domenica, and Beris, Photis. "Anemia in Clinical Practice: Introduction." Seminars in hematology vol. 52,4 (2015): 259-60. doi: https://doi.org/10.1053/j.seminhematol.2015.07.001
Cappellini MD, Beris P. Anemia in Clinical Practice: Introduction. Semin Hematol. 2015 Oct;52(4):259-60. doi: 10.1053/j.seminhematol.2015.07.001. Epub 2015 Jul 10. PMID: 26404437.
Copy Download .nbib Format: NLM
Introduction.

Seminars in hematology

Malcovati L.
PMID: 28958285
Semin Hematol. 2017 Jul;54(3):129-132. doi: 10.1053/j.seminhematol.2017.07.001. Epub 2017 Jul 20.

No abstract available.

Cite
Malcovati L. Introduction. Semin Hematol. 2017;54(3):129-132doi: 10.1053/j.seminhematol.2017.07.001.
Malcovati, L. (2017). Introduction. Seminars in hematology, 54(3), 129-132. https://doi.org/10.1053/j.seminhematol.2017.07.001
Malcovati, Luca. "Introduction." Seminars in hematology vol. 54,3 (2017): 129-132. doi: https://doi.org/10.1053/j.seminhematol.2017.07.001
Malcovati L. Introduction. Semin Hematol. 2017 Jul;54(3):129-132. doi: 10.1053/j.seminhematol.2017.07.001. Epub 2017 Jul 20. PMID: 28958285.
Copy Download .nbib Format: NLM
5th Intercontinental Cooperative ITP Study Group (ICIS) expert meeting in Flüeli-Ranft, Switzerland, September 2015.

Seminars in hematology

Imbach P, Kühne T.
PMID: 27312153
Semin Hematol. 2016 Apr;53:S1. doi: 10.1053/j.seminhematol.2016.04.001. Epub 2016 Apr 06.

No abstract available.

Cite
Imbach P, Kühne T. 5th Intercontinental Cooperative ITP Study Group (ICIS) expert meeting in Flüeli-Ranft, Switzerland, September 2015. Semin Hematol. 2016;53:S1doi: 10.1053/j.seminhematol.2016.04.001.
Imbach, P., & Kühne, T. (2016). 5th Intercontinental Cooperative ITP Study Group (ICIS) expert meeting in Flüeli-Ranft, Switzerland, September 2015. Seminars in hematology, 53S1. https://doi.org/10.1053/j.seminhematol.2016.04.001
Imbach, Paul, and Kühne, Thomas. "5th Intercontinental Cooperative ITP Study Group (ICIS) expert meeting in Flüeli-Ranft, Switzerland, September 2015." Seminars in hematology vol. 53 (2016): S1. doi: https://doi.org/10.1053/j.seminhematol.2016.04.001
Imbach P, Kühne T. 5th Intercontinental Cooperative ITP Study Group (ICIS) expert meeting in Flüeli-Ranft, Switzerland, September 2015. Semin Hematol. 2016 Apr;53:S1. doi: 10.1053/j.seminhematol.2016.04.001. Epub 2016 Apr 06. PMID: 27312153.
Copy Download .nbib Format: NLM
Therapy of mantle cell lymphoma: new treatment options in an old disease or vice versa?.

Seminars in hematology

Dreyling M.
PMID: 21782055
Semin Hematol. 2011 Jul;48(3):145-7. doi: 10.1053/j.seminhematol.2011.06.003.

No abstract available.

Cite
Dreyling M. Therapy of mantle cell lymphoma: new treatment options in an old disease or vice versa?. Semin Hematol. 2011;48(3):145-7doi: 10.1053/j.seminhematol.2011.06.003.
Dreyling, M. (2011). Therapy of mantle cell lymphoma: new treatment options in an old disease or vice versa?. Seminars in hematology, 48(3), 145-7. https://doi.org/10.1053/j.seminhematol.2011.06.003
Dreyling, Martin. "Therapy of mantle cell lymphoma: new treatment options in an old disease or vice versa?." Seminars in hematology vol. 48,3 (2011): 145-7. doi: https://doi.org/10.1053/j.seminhematol.2011.06.003
Dreyling M. Therapy of mantle cell lymphoma: new treatment options in an old disease or vice versa?. Semin Hematol. 2011 Jul;48(3):145-7. doi: 10.1053/j.seminhematol.2011.06.003. PMID: 21782055.
Copy Download .nbib Format: NLM
Molecular targeted approaches in mantle cell lymphoma.

Seminars in hematology

Weniger MA, Wiestner A.
PMID: 21782064
Semin Hematol. 2011 Jul;48(3):214-26. doi: 10.1053/j.seminhematol.2011.05.001.

Mantle cell lymphoma (MCL) is a malignancy of mature B cells characterized by the translocation t(11;14) that leads to aberrant expression of cyclin D1. Response to first-line chemotherapy is good, but most patients relapse, resulting in a median survival...

Cite
Weniger MA, Wiestner A. Molecular targeted approaches in mantle cell lymphoma. Semin Hematol. 2011;48(3):214-26doi: 10.1053/j.seminhematol.2011.05.001.
Weniger, M. A., & Wiestner, A. (2011). Molecular targeted approaches in mantle cell lymphoma. Seminars in hematology, 48(3), 214-26. https://doi.org/10.1053/j.seminhematol.2011.05.001
Weniger, Marc A, and Wiestner, Adrian. "Molecular targeted approaches in mantle cell lymphoma." Seminars in hematology vol. 48,3 (2011): 214-26. doi: https://doi.org/10.1053/j.seminhematol.2011.05.001
Weniger MA, Wiestner A. Molecular targeted approaches in mantle cell lymphoma. Semin Hematol. 2011 Jul;48(3):214-26. doi: 10.1053/j.seminhematol.2011.05.001. PMID: 21782064; PMCID: PMC3143377.
Copy Download .nbib Format: NLM
Therapeutic complement modulation for hematological diseases: Where we stand and where we are going.

Seminars in hematology

Risitano AM.
PMID: 30032746
Semin Hematol. 2018 Jul;55(3):113-117. doi: 10.1053/j.seminhematol.2018.05.012. Epub 2018 May 29.

No abstract available.

Cite
Risitano AM. Therapeutic complement modulation for hematological diseases: Where we stand and where we are going. Semin Hematol. 2018;55(3):113-117doi: 10.1053/j.seminhematol.2018.05.012.
Risitano, A. M. (2018). Therapeutic complement modulation for hematological diseases: Where we stand and where we are going. Seminars in hematology, 55(3), 113-117. https://doi.org/10.1053/j.seminhematol.2018.05.012
Risitano, Antonio M. "Therapeutic complement modulation for hematological diseases: Where we stand and where we are going." Seminars in hematology vol. 55,3 (2018): 113-117. doi: https://doi.org/10.1053/j.seminhematol.2018.05.012
Risitano AM. Therapeutic complement modulation for hematological diseases: Where we stand and where we are going. Semin Hematol. 2018 Jul;55(3):113-117. doi: 10.1053/j.seminhematol.2018.05.012. Epub 2018 May 29. PMID: 30032746.
Copy Download .nbib Format: NLM
Hodgkin lymphoma: Introduction.

Seminars in hematology

Engert A, Vassilakopoulos TP.
PMID: 27496303
Semin Hematol. 2016 Jul;53(3):137-8. doi: 10.1053/j.seminhematol.2016.05.001. Epub 2016 May 12.

No abstract available.

Cite
Engert A, Vassilakopoulos TP. Hodgkin lymphoma: Introduction. Semin Hematol. 2016;53(3):137-8doi: 10.1053/j.seminhematol.2016.05.001.
Engert, A., & Vassilakopoulos, T. P. (2016). Hodgkin lymphoma: Introduction. Seminars in hematology, 53(3), 137-8. https://doi.org/10.1053/j.seminhematol.2016.05.001
Engert, Andreas, and Vassilakopoulos, Theodoros P. "Hodgkin lymphoma: Introduction." Seminars in hematology vol. 53,3 (2016): 137-8. doi: https://doi.org/10.1053/j.seminhematol.2016.05.001
Engert A, Vassilakopoulos TP. Hodgkin lymphoma: Introduction. Semin Hematol. 2016 Jul;53(3):137-8. doi: 10.1053/j.seminhematol.2016.05.001. Epub 2016 May 12. PMID: 27496303.
Copy Download .nbib Format: NLM
Sickle cell disease-Unanswered questions and future directions in therapy.

Seminars in hematology

Thein SL, Tisdale J.
PMID: 29958561
Semin Hematol. 2018 Apr;55(2):51-52. doi: 10.1053/j.seminhematol.2018.05.010. Epub 2018 May 26.

No abstract available.

Cite
Thein SL, Tisdale J. Sickle cell disease-Unanswered questions and future directions in therapy. Semin Hematol. 2018;55(2):51-52doi: 10.1053/j.seminhematol.2018.05.010.
Thein, S. L., & Tisdale, J. (2018). Sickle cell disease-Unanswered questions and future directions in therapy. Seminars in hematology, 55(2), 51-52. https://doi.org/10.1053/j.seminhematol.2018.05.010
Thein, Swee Lay, and Tisdale, John. "Sickle cell disease-Unanswered questions and future directions in therapy." Seminars in hematology vol. 55,2 (2018): 51-52. doi: https://doi.org/10.1053/j.seminhematol.2018.05.010
Thein SL, Tisdale J. Sickle cell disease-Unanswered questions and future directions in therapy. Semin Hematol. 2018 Apr;55(2):51-52. doi: 10.1053/j.seminhematol.2018.05.010. Epub 2018 May 26. PMID: 29958561.
Copy Download .nbib Format: NLM
VEXAS within the spectrum of rheumatologic disease.

Seminars in hematology

Koster MJ, Warrington KJ.
PMID: 34802543
Semin Hematol. 2021 Oct;58(4):218-225. doi: 10.1053/j.seminhematol.2021.10.002. Epub 2021 Oct 09.

The identification of the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome as a myeloid-driven inflammatory disease resulting from somatic mutations in the UBA1 gene further exposes the increasingly recognized overlap between hematologic disturbances and auto-immunity and/or auto-inflammatory presentations....

Cite
Koster MJ, Warrington KJ. VEXAS within the spectrum of rheumatologic disease. Semin Hematol. 2021;58(4):218-225doi: 10.1053/j.seminhematol.2021.10.002.
Koster, M. J., & Warrington, K. J. (2021). VEXAS within the spectrum of rheumatologic disease. Seminars in hematology, 58(4), 218-225. https://doi.org/10.1053/j.seminhematol.2021.10.002
Koster, Matthew J, and Warrington, Kenneth J. "VEXAS within the spectrum of rheumatologic disease." Seminars in hematology vol. 58,4 (2021): 218-225. doi: https://doi.org/10.1053/j.seminhematol.2021.10.002
Koster MJ, Warrington KJ. VEXAS within the spectrum of rheumatologic disease. Semin Hematol. 2021 Oct;58(4):218-225. doi: 10.1053/j.seminhematol.2021.10.002. Epub 2021 Oct 09. PMID: 34802543.
Copy Download .nbib Format: NLM
Shaping the bone through iron and iron-related proteins.

Seminars in hematology

Ledesma-Colunga MG, Weidner H, Vujic Spasic M, Hofbauer LC, Baschant U, Rauner M.
PMID: 34389111
Semin Hematol. 2021 Jul;58(3):188-200. doi: 10.1053/j.seminhematol.2021.06.002. Epub 2021 Jun 27.

Well-controlled iron levels are indispensable for health. Iron deficiency is the most common cause of anemia, whereas iron overload, either hereditary or secondary due to disorders of ineffective erythropoiesis, causes widespread organ failure. Bone is particularly sensitive to fluctuations...

Cite
Ledesma-Colunga MG, Weidner H, Vujic Spasic M, et al. Shaping the bone through iron and iron-related proteins. Semin Hematol. 2021;58(3):188-200doi: 10.1053/j.seminhematol.2021.06.002.
Ledesma-Colunga, M. G., Weidner, H., Vujic Spasic, M., Hofbauer, L. C., Baschant, U., & Rauner, M. (2021). Shaping the bone through iron and iron-related proteins. Seminars in hematology, 58(3), 188-200. https://doi.org/10.1053/j.seminhematol.2021.06.002
Ledesma-Colunga, Maria G, et al. "Shaping the bone through iron and iron-related proteins." Seminars in hematology vol. 58,3 (2021): 188-200. doi: https://doi.org/10.1053/j.seminhematol.2021.06.002
Ledesma-Colunga MG, Weidner H, Vujic Spasic M, Hofbauer LC, Baschant U, Rauner M. Shaping the bone through iron and iron-related proteins. Semin Hematol. 2021 Jul;58(3):188-200. doi: 10.1053/j.seminhematol.2021.06.002. Epub 2021 Jun 27. PMID: 34389111.
Copy Download .nbib Format: NLM
TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics.

Seminars in hematology

Guan Y, Hasipek M, Tiwari AD, Maciejewski JP, Jha BK.
PMID: 33509440
Semin Hematol. 2021 Jan;58(1):27-34. doi: 10.1053/j.seminhematol.2020.12.002. Epub 2020 Dec 28.

TET2 is one of the most frequently mutated genes in myeloid neoplasms. TET2 loss-of-function perturbs myeloid differentiation and causes clonal expansion. Despite extensive knowledge regarding biochemical mechanisms underlying distorted myeloid differentiation, targeted therapies are lagging. Here we review known...

Cite
Guan Y, Hasipek M, Tiwari AD, et al. TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics. Semin Hematol. 2020;58(1):27-34doi: 10.1053/j.seminhematol.2020.12.002.
Guan, Y., Hasipek, M., Tiwari, A. D., Maciejewski, J. P., & Jha, B. K. (2021). TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics. Seminars in hematology, 58(1), 27-34. https://doi.org/10.1053/j.seminhematol.2020.12.002
Guan, Yihong, et al. "TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics." Seminars in hematology vol. 58,1 (2021): 27-34. doi: https://doi.org/10.1053/j.seminhematol.2020.12.002
Guan Y, Hasipek M, Tiwari AD, Maciejewski JP, Jha BK. TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics. Semin Hematol. 2021 Jan;58(1):27-34. doi: 10.1053/j.seminhematol.2020.12.002. Epub 2020 Dec 28. PMID: 33509440; PMCID: PMC7938524.
Copy Download .nbib Format: NLM
Epigenetic activities in erythroid cell gene regulation.

Seminars in hematology

Wang Y, Yu L, Engel JD, Singh SA.
PMID: 33509442
Semin Hematol. 2021 Jan;58(1):4-9. doi: 10.1053/j.seminhematol.2020.11.007. Epub 2020 Dec 15.

Interest in the role of epigenetic mechanisms in human biology has exponentially increased over the past several decades. The multitude of opposing and context-dependent chromatin-modifying enzymes/coregulator complexes is just beginning to be understood at a molecular level. This science...

Cite
Wang Y, Yu L, Engel JD, et al. Epigenetic activities in erythroid cell gene regulation. Semin Hematol. 2020;58(1):4-9doi: 10.1053/j.seminhematol.2020.11.007.
Wang, Y., Yu, L., Engel, J. D., & Singh, S. A. (2021). Epigenetic activities in erythroid cell gene regulation. Seminars in hematology, 58(1), 4-9. https://doi.org/10.1053/j.seminhematol.2020.11.007
Wang, Yu, et al. "Epigenetic activities in erythroid cell gene regulation." Seminars in hematology vol. 58,1 (2021): 4-9. doi: https://doi.org/10.1053/j.seminhematol.2020.11.007
Wang Y, Yu L, Engel JD, Singh SA. Epigenetic activities in erythroid cell gene regulation. Semin Hematol. 2021 Jan;58(1):4-9. doi: 10.1053/j.seminhematol.2020.11.007. Epub 2020 Dec 15. PMID: 33509442; PMCID: PMC7846819.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 70 entries